[Stock in Focus] Clobot Drops 18% on 200 Billion Won Paid-in Capital Increase

Shares of Clobot, which has decided on a capital increase of 200 billion won, fell 18% in early trading compared to the previous session.

As of 9:42 a.m. on April 6, Clobot shares were trading at 42,150 won, down 18.16% (9,350 won) from the previous trading day.

The announcement of a large-scale paid-in capital increase by Clobot appears to have dampened investor sentiment. According to the Financial Supervisory Service’s Electronic Disclosure System (DART), Clobot announced on April 3 that it would issue 5,494,500 new common shares. This represents approximately 22% of its current outstanding common shares (24,992,139 shares).

The capital increase will be conducted through a rights offering to existing shareholders, followed by a public offering for any forfeited shares. This means that existing shareholders are given priority to purchase new shares, and any remaining shares are then sold publicly to general investors.

The planned issuance price is 36,400 won per share, with the total amount to be raised estimated at approximately 200 billion won. The funds raised are scheduled to be used for 37,663.8 million won in operating funds and 162,336 million won for the acquisition of securities in other companies.

The capital increase method, which places a financial burden on shareholders, and the high dilution ratio of 22% appear to have had a negative impact on the market.

This content was produced with the assistance of AI translation services.